Retina Suisse
Company Overview
Management
Brigitte Hübschi
Köniz
Vice-chairperson of the board
Joint signing authority (any two to sign)
Christina Fasser
Glarus Nord
Joint signing authority (any two to sign)
Rita
Herrliberg
Joint signing authority (any two to sign)
Matthias Bütikofer
Zürich
Member of the board + treasurer
Joint signing authority (any two to sign)
Jeannine Sutter
Basel
Member of the board
Without signing authority
Stephan
Emmen
Geschäftsleiter
Joint signing authority (any two to sign)
Tamara Zoller
Lugano
Member of the board
Without signing authority
Laurent Delétraz
Plan-les-Ouates
Chairperson of the board
Joint signing authority (any two to sign)
Eveline Zimmermann
Wallisellen
Member of the board + sekretärin
Joint signing authority (any two to sign)
Sibylla De Vries
Coppet
Member of the board
Without signing authority
Josephine Hayley-Barker
Zürich
Member of the board
Without signing authority
Rudolf Küchler
Kerns
Member of the board
Without signing authority
Claudia Genini
Bern
Member of the board
Without signing authority
Markus Imboden
Männedorf
Member of the board
Without signing authority
Building smart people network graph...
Fetching people and their companies
| No. | Journal No. | Journal date | SOGC | SOGC date | Page / ID |
|---|---|---|---|---|---|
| 1 | 38817 | 29.08.2025 | 169 | 03.09.2025 | 1006423389 |
| 2 | 34832 | 23.08.2023 | 165 | 28.08.2023 | 1005824502 |
| 3 | 38378 | 26.09.2022 | 189 | 29.09.2022 | 1005571424 |
| 4 | 30257 | 02.08.2019 | 150 | 07.08.2019 | 1004691048 |
| 5 | 26554 | 23.07.2015 | 143 | 28.07.2015 | 2292537 |
| 6 | 1034 | 08.01.2015 | 7 | 13.01.2015 | 1925611 |
| 7 | 16294 | 14.05.2014 | 95 | 19.05.2014 | 1508235 |
| 8 | 25912 | 14.07.2011 | 138 | 19.07.2011 | 6262736 |
| 9 | 193 | 04.01.2010 | 5 | 08.01.2010 | 34/5431428 |
| 10 | 8364 | 26.03.2008 | 62 | 01.04.2008 | 21/4409222 |
Company Purpose
Retina Suisse bezweckt: die Information ihrer Mitglieder über Retinitis pigmentosa (RP), Makuladegeneration, Usher-Syndrom und andere Erkrankungen des Augenhintergrundes, deren Ursachen, Auswirkungen, Bewältigung und Therapiemöglichkeiten; die Förderung der Forschung auf dem Gebiet der Retinitis pigmentosa (RP), Makuladegeneration, Usher-Syndrom und anderen Erkrankungen des Augenhintergrundes; die Orientierung einer breiteren Öffentlichkeit über Retinitis pigmentosa (RP), Makuladegeneration, Usher-Syndrom und andere Erkrankungen des Augenhintergrundes und deren Auswirkungen für die betroffenen Patient*innen.